"Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials." by Torsten H. Nielsen

Article

Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.

Cancer Research (2013)

Torsten H. Nielsen, McGill University
Zuanel Diaz, 2QCROC, Montreal, Quebec, Canada;
Rosa Christodoulopoulos, McGill University
Lu Yao, McGill University
Samia Qureshi, 2QCROC, Montreal, Quebec, Canada;
Naciba Benlimame, McGill University
Errol Camlioglu, McGill University
Michael Crump, 3Princess Margaret Hospital, Toronto, Ontario, Canada;
Ryan D. Morin, Simon Fraser University
Nathalie Johnson, McGill University
Tina P. Haliotis, McGill University
Wilson H. Miller, McGill University
Sarit Assouline, McGill University
Koren K. Mann, McGill University

Link

Disciplines

Publication Date

April 15, 2013

DOI

10.1158/1538-7445.AM2013-64

Citation Information

Torsten H. Nielsen, Zuanel Diaz, Rosa Christodoulopoulos, Lu Yao, et al.. "Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials." Cancer Research Vol. 73 (2013) p. 64 - 64
Available at: http://works.bepress.com/zuanel-diaz/21/